Inloggen op uw account

Lukt u niet om in te loggen? Neem dan contact met ons op.

Wachtwoord vergeten?

Ondernemers in Life Sciences
en Medische Technologie

Lid worden

Progress in Personalised Medicine

Donderdag, 16 mei 2019

SKiN-HUID cordially invites you to:

Progress in Personalised Medicine

Developing a novel biopharmaceutical, from bench to production

Registration no longer possible. The meeting has been postponed, for more information about the project please contact us at

About the event

A major challenge in the development of biopharmaceuticals is achieving clinical grade products for clinical evaluation. Under the framework of the Interreg V Netherlands and Flanders -project SkiN-HUID, Basic Pharma and MosaMedix, Universities of Maastricht, Antwerp and the Flemish Institute for Biotechnology (VIB) at the KU Leuven joined forces.

SKiN-HUID develops a novel treatment of skin cancer that combines administration of a biopharmaceutical medicine targeting cancer cells and application of electrical and hyperthermal stimulation of the cancer that enhances the efficacy of the biopharmaceutical medicine.

Within SKiN-HUID the consortium aims to overcome the major hurdle of bringing a novel biopharmaceutical product to the clinic: the GMP-production of clinical grade biopharmaceutical medicine for the first phase of clinical studies. Basic Pharma set up a novel pilot plant for the GMP-production of biopharmaceutical medicines. This facility forms an essential part of the value chain linking preclinical and clinical evaluation of the efficacy of biopharmaceutical medicines.

Collaboration between University and Industry, access to finance, infrastructure and regulatory insight is paramount in mastering this challenge. SKiN-HUID cordially invites you to join our mission in accelerating personalised medicine innovations. This workshop is supported by LifetecZONe.